+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epivir"

Global HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
HIV Disease Coverage Forecast and Market Analysis to 2024 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2024

  • Report
  • January 2019
  • 717 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Epivir is a brand name for the antiretroviral drug lamivudine, which is used to treat HIV/AIDS. It is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the action of the enzyme reverse transcriptase, which is necessary for the virus to replicate. Epivir is usually prescribed in combination with other antiretroviral drugs to treat HIV infection. It is available in tablet, oral solution, and injection forms. Epivir is used to reduce the amount of HIV in the body and to prevent the virus from multiplying. It is also used to reduce the risk of HIV transmission from mother to child during pregnancy and delivery. Epivir is generally well tolerated, but side effects may include nausea, vomiting, headache, and diarrhea. Epivir is manufactured by several companies, including GlaxoSmithKline, Bristol-Myers Squibb, and Teva Pharmaceuticals. It is available in many countries around the world, including the United States, Canada, and the United Kingdom. Show Less Read more